Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Typical carcinoids (TC) are well-differentiated neuroendocrine neoplasms of the lung with generally favourable prognosis. Recurrence is rare in TC patients treated with curative intent, yet current ENETS guidelines recommend extensive follow-up, including regular and long-term imaging.
Conference:
Presenting Author: Lau T
Authors: Lau T, Soldath P, Rewitz K, Jepsen P, Knigge U,
Keywords: typical carcinoid, lung nen, follow-up programme,
#4201 Prospective analysis of the risk of post-surgical recurrence in lung typical carcinoid
Introduction: In localized/locally advanced forms of NET, radical surgical resection represents the standard of care.
Conference:
Presenting Author:
Authors: Paravani P, Russo F, Mazzilli R, Zamponi V, Mancini C,
Keywords: Lung typical carcinoid, recurrence-free-survival, Ki-67%, Male sex, Mitotic Index, TTF-1, Surgery,
Introduction: The current diagnosis of lung typical carcinoids (TCs) and atypical carcinoids (ACs) can be ambiguous for small biopsies containing limited tissues.
Conference:
Presenting Author: Guo Y
Authors: Guo Y, Su F, Hu S, Chen R, Chen Q,
Keywords: lung carcinoid, typical carcinoid, atypical carcinoid, machine-learning, diagnosis, genomic features,
#3961 Enhancer heterogeneity of lung carcinoids reveals sensitivity to FGF signaling inhibition
Introduction: Well-differentiated low grade lung carcinoids are histo-pathologically classified as typical and atypical, but each subtype is still heterogenous both at the molecular level and its clinical manifestation. Therefore, the treatment of these patients is challenging. The two main challenges are the lack of effective drug treatments and the lack of reliable biomarkers to guide management since the disease in patients with the same tumor grade/stage often has different clinical courses. The genetic, epigenetic, and developmental programs that drive lung carcinoids remain obscure, limiting our abilities to suggest new biomarkers and drug targets.
Conference:
Presenting Author: Drier Y
Authors: Davis E, Avniel-Polak S, Hecht M, Grozinsky-Glasberg S, Drier Y,
Keywords: FGF Signaling, Lung carcinoids, Enhancers,
Introduction: Atypical lung carcinoids are a highly heterogeneous group of tumors, some of which have more malignant potential, which makes the search for additional morphological prognostic criteria relevant.
Conference:
Presenting Author:
Authors: Gurevich L, Bondarenco E, Markarova E, Kagoniya L,
Keywords: lung carcinoid, atypical, prognosis, TTF1, cytokeratin 19,